MDGL - Madrigal Pharma Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (%) NVAX (1.83%) LAKE (4.97%) AGRX (8.77%) AAPL (-0.29%) BAC (-1.7%) PTON (1.47%) LEDS (0%) APT (17.88%) AMRN (-2.61%) AAOI (-1.9%) JPM (-2.49%) JNJ (-0.15%) JEF (-1.09%) IWM (-1.23%) INTC (8.14%) HOME (-0.5%) HEXO (-6%) HAL (-2.04%) GPRO (0.46%) FDX (-0.53%) FB (-0.83%) ENDP (-10.24%) ELOX (-5.55%) DIS (-1.5%)

The Daily Biotech Pulse: FDA Nod For Epi...	01/24/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) ...

IBI Blogs On Holidays: Merry Christmas, ...	12/25/19
This morning, I sent you the Christmas gift, i.e. the research on Madrigal Pharmaceuticals (MDGL). In the spirit of the holiday, I'm giving you anothe...

Madrigal Pharmaceuticals : Reports 2019 ...	11/06/19
Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights CONSHOHOCKEN, Pa., November 6, 2019 -- Madrigal??? \| November 6, ...

Hedge Funds Are Dumping Madrigal Pharmac...	10/26/19
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook a...

The Daily Biotech Pulse: Arbutus Halts H...	10/04/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Ap...

Madrigal, Galmed, And Galectin In Phase ...	05/22/19
No summary available.

Noteworthy Friday Option Activity: MDGL,...	05/17/19
Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Madrigal Pharmaceuticals Inc Symb...

Madrigal Pharmaceuticals beats by $0.06	05/08/19
No summary available.

IPO Update: Axcella Health Readies Plan ...	05/02/19
No summary available.

MGL-3196: Not Ideal, But Currently The B...	04/16/19
No summary available.

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Service Name	Trader	% Success
AungPan Thar's Swing trading	Kyaw Aung	72.00 %	Subscribe
Long Only Biotech/Pharma	Biotech Buys	33.00 %	Follow
Free Biotech Holdings	Scientia Equity Research	0.00 %	Follow

Service Name

Trader

% Success

AungPan Thar's Swing trading

Kyaw Aung

72.00 %

Long Only Biotech/Pharma

Biotech Buys

33.00 %

Free Biotech Holdings

Scientia Equity Research

0.00 %

Previous Close	$81.68	Open	$82.02
Volume	268.4K	Market Cap	1.421B
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

MDGL - Madrigal Pharmaceuti...

$76.98 -4.7[-5.76%]

Add to New List:

Day

52 Week

ANALYST RATINGS

100.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $MDGL

About Us

Product Types

Strategies

Follow Us

Secure Payments

Buy rating	01/09/20
UBS upgrades from Neutral to Buy rating and raises Price Target from $125.00 to $127.00

Buy rating	12/02/19
Citi maintains Buy rating and lowers Price Target from $173.00 to $166.00

Buy rating	09/17/19
Citigroup maintains Buy rating and lowers Price Target from $186.00 to $173.00